Global Pregnancy and Ovulation Testing Supply, Demand and Key Producers, 2026-2032

November 2026 | 128 pages | ID: G0D029010DC4EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Pregnancy and Ovulation Testing market size is expected to reach $ 991 million by 2032, rising at a market growth of 5.1% CAGR during the forecast period (2026-2032).

Pregnancy and Ovulation Testing refers to in-vitro diagnostic products used to identify pregnancy and evaluate the fertile window through the detection of reproductive hormones. Pregnancy testing is primarily based on human chorionic gonadotropin, particularly qualitative hCG detection in urine for home self-testing and point-of-care use, while professional products may also support serum testing. Ovulation testing primarily identifies the urinary luteinizing hormone surge preceding ovulation, with advanced systems extending monitoring to multiple fertility hormones such as estrogen metabolites alongside LH. The product scope covers visual line-read tests, digital display tests and smartphone- or reader-assisted systems, delivered in strip/dipstick, cassette, midstream and reader-based formats. The research focuses on Pregnancy and Ovulation Testing products used for home self-testing, hospitals and clinics, fertility centers and diagnostic laboratories, reflecting both consumer self-diagnosis and professional reproductive-health testing applications.

Key Findings

Pregnancy testing remains centered on urine hCG rapid detection products

Ovulation testing is primarily built around urinary LH surge detection

Visual line tests remain a foundational conventional product format

Digital and reader-assisted formats reduce ambiguity in result interpretation

Multi-hormone testing extends ovulation assessment beyond single-LH detection

Home self-testing is the core consumer application scenario

Market Trends

Pregnancy and Ovulation Testing is shifting from simple qualitative line interpretation toward earlier detection, clearer digital outputs, individualized hormone assessment and connected fertility management. Conventional lateral-flow products retain their importance because of low complexity, portability and broad channel suitability, but premium product development increasingly focuses on reducing interpretation uncertainty and providing more actionable information. Digital ovulation systems can automatically interpret test results, while more advanced products monitor both LH and estrogen-related biomarkers to identify a broader fertile window rather than relying solely on a fixed LH threshold. Smartphone-assisted readers and reusable digital devices are further extending the category from a single test result toward cycle tracking and longitudinal hormone-pattern management. In pregnancy testing, product innovation is concentrated on lower detection thresholds, earlier testing windows, clearer result presentation and digital formats. The continued appearance of digital and early-detection pregnancy tests in regulatory databases also demonstrates that product differentiation is increasingly occurring around user experience, sensitivity and interpretation rather than around the underlying hCG biomarker itself.

Market Dynamics

Drivers

Demand is supported by the combination of reproductive-health awareness, preference for private and convenient testing, and the ability of urine-based rapid tests to provide results without laboratory infrastructure. Pregnancy testing addresses a recurring and time-sensitive diagnostic need, while ovulation testing supports consumers actively planning conception and seeking more precise identification of fertile days. The relatively simple workflow of strips and midstream devices supports wide availability through pharmacies and consumer channels, while professional hCG products remain relevant in hospitals, clinics and laboratories. The increasing integration of fertility testing with digital interpretation and cycle-management tools is also widening the functional value of the category beyond a single qualitative result.

Restraints

The primary limitation is that biological variability and testing timing directly affect result reliability in real-world use. Pregnancy tests may produce false-negative results when used too early because urinary hCG has not yet reached the detection threshold, while improper sampling or interpretation can further reduce effective accuracy. Ovulation testing faces a different limitation: an LH surge predicts impending ovulation but does not itself confirm that ovulation has occurred, and individual hormone patterns, irregular cycles, medical conditions and certain fertility medications can complicate result interpretation. These limitations mean that improvements in analytical sensitivity alone cannot completely eliminate user-related and physiological uncertainty.

Opportunities

The clearest product opportunity lies in moving from single-marker qualitative testing toward integrated fertility intelligence. Digital readers, reusable devices, smartphone-assisted interpretation and multi-hormone testing can create a more differentiated proposition than conventional single-use visual strips. Dual-hormone systems that combine LH with estrogen-related biomarkers can identify a broader fertility window, while newer platforms are exploring additional reproductive hormones and longitudinal pattern analysis. At the same time, conventional low-cost tests retain substantial opportunities in markets where pharmacy penetration, e-commerce availability and consumer awareness are still developing. This creates room for parallel growth of value-oriented visual tests and premium digital fertility-management products rather than a complete substitution of one format by another.

Challenges

Competition increasingly operates across several dimensions simultaneously: analytical performance, manufacturing consistency, regulatory compliance, brand trust, retail access, digital user experience and price. Conventional pregnancy and ovulation strips have relatively standardized core immunochromatographic technology, making product differentiation difficult when suppliers compete primarily on sensitivity specifications and cost. At the premium end, digital and multi-hormone systems require stronger algorithm development, device reliability, user-interface design and consumer education. Manufacturers must also manage differences in product classification, labeling, self-test regulation and distribution requirements across markets. As a result, scaling globally requires not only manufacturing capability but also sustained regulatory, channel and brand investment.

Industry Chain Analysis

The Pregnancy and Ovulation Testing industry chain begins with biological reagents and diagnostic materials, including hormone-specific antibodies, membrane materials, sample and absorbent pads, signal-generating materials such as colloidal gold, plastic components and packaging. Digital and reader-based products add electronic components, optical or signal-reading modules, displays, batteries, connectivity components and software algorithms. Midstream manufacturers undertake reagent formulation and coating, membrane assembly, strip cutting, housing assembly, calibration, quality control, packaging and regulatory documentation. The established use of colloidal-gold platforms for hCG and LH rapid tests illustrates the continued importance of mature lateral-flow manufacturing infrastructure, while digital products add a separate electronics and software layer to the value chain. Downstream routes differ by positioning. Consumer-oriented products move primarily through pharmacy, mass retail and online channels, whereas professional products are supplied to hospitals, clinics, fertility centers and diagnostic laboratories. Value creation is therefore increasingly bifurcated: conventional visual tests compete through scalable manufacturing, consistent quality and channel efficiency, while premium products rely more heavily on brand recognition, simplified interpretation, multi-hormone capability and digital functionality.

Segment Insights

By testing purpose, Pregnancy Tests and Ovulation Tests address distinct but closely connected reproductive-health needs. Pregnancy testing is centered on hCG detection and spans both consumer urine testing and professional urine or serum testing. Professional rapid hCG assays are available in cassette and dipstick formats for point-of-care environments, while consumer products emphasize midstream convenience and clear result interpretation. Ovulation testing is primarily based on urinary LH detection and generally involves repeated testing over several days within a menstrual cycle, supporting multi-test packages and reusable-reader models. The segment is also becoming technologically broader as dual-hormone systems use LH together with estrogen-related signals to identify high- and peak-fertility periods.

By result-reading method and physical form, visual line-read products constitute the conventional foundation of the market, spanning test strips, cassettes and midstream devices. Their competitive advantages are simplicity, low hardware requirements and suitability for both branded retail products and large-scale manufacturing. Digital display and reader-assisted products occupy a more differentiated position by automatically interpreting test signals and reducing ambiguity associated with comparing line intensity. Smartphone-assisted systems extend this approach further by storing results and tracking hormone or cycle patterns. Consequently, technological segmentation is increasingly moving from a simple distinction between test formats toward a broader separation between single-result diagnostic products and connected fertility-monitoring systems.

Downstream Market Opportunities

Home self-testing represents the central consumer-facing opportunity because pregnancy and ovulation testing both benefit from privacy, immediate access and simple urine-based workflows. Pharmacies and online retail enable broad distribution of conventional and premium formats, while digital fertility products create additional opportunities among consumers seeking more structured conception planning. Professional demand remains differentiated: hospitals and clinics use rapid pregnancy testing as part of routine clinical decision-making, diagnostic laboratories may use urine or serum hCG tests, and fertility centers have demand for ovulation and reproductive-hormone assessment. QuidelOrtho's professional hCG products, for example, support both urine and serum specimens, demonstrating that the category extends beyond the consumer self-test channel.

Regional Insights

North America represents a highly developed regulatory and commercial environment for Pregnancy and Ovulation Testing, with a broad range of over-the-counter and waived urine hCG products, including traditional visual and digital pregnancy tests. The FDA database continues to record new early-detection and digital products, indicating an active replacement and product-differentiation cycle rather than a static commodity market. Europe also supports a mature self-testing model through pharmacy and consumer diagnostic channels, with manufacturers such as BIOSYNEX offering both pregnancy and ovulation self-tests alongside professional rapid diagnostics.

Asia-Pacific has a structurally different opportunity profile. China hosts multiple manufacturers with broad hCG and LH rapid-test portfolios across strip, cassette and midstream formats, supporting both domestic supply and international manufacturing, while Japan maintains established consumer ovulation-testing products through pharmacy-regulated channels. South Korea also provides examples of digital and smartphone-connected fertility testing. The region therefore combines cost-efficient rapid-test manufacturing with growing capability in higher-value digital fertility products. Market opportunities differ significantly by country according to regulation, pharmacy access, fertility awareness, digital-health adoption and consumer purchasing power, making localization of product positioning and channel strategy particularly important.

Report Scope

This report studies the global Pregnancy and Ovulation Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pregnancy and Ovulation Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pregnancy and Ovulation Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

  • Global Pregnancy and Ovulation Testing total market, 2021-2032, (USD Million)
  • Global Pregnancy and Ovulation Testing total market by region & country, CAGR, 2021-2032, (USD Million)
  • U.S. VS China: Pregnancy and Ovulation Testing total market, key domestic companies, and share, (USD Million)
  • Global Pregnancy and Ovulation Testing revenue by player, revenue and market share 2021-2026, (USD Million)
  • Global Pregnancy and Ovulation Testing total market by Type, CAGR, 2021-2032, (USD Million)
  • Global Pregnancy and Ovulation Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Pregnancy and Ovulation Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SPD (Clearblue), First Response, Gregory Pharmaceutical (e.p.t), Equinox Biotech, Wondfo, Easy@Home, BlueCross, Fairhaven Health, PRIMA Lab, Cyclotest, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pregnancy and Ovulation Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Pregnancy and Ovulation Testing Market, By Region:

  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World

Market Segmentation

Global Pregnancy and Ovulation Testing Market, Segmentation by Type:

  • Coloration Test
  • Digital Test

Global Pregnancy and Ovulation Testing Market, Segmentation by Purpose of Testing:

  • Pregnancy Test
  • Ovulation Test

Global Pregnancy and Ovulation Testing Market, Segmentation by Biomarker:

  • hCG-Based Test
  • LH-Based Test
  • Multi-Hormone Test

Global Pregnancy and Ovulation Testing Market, Segmentation by Application:

  • Fertility Centers
  • Hospitals
  • Clinics
  • Others

Companies Profiled:

  • SPD (Clearblue)
  • First Response
  • Gregory Pharmaceutical (e.p.t)
  • Equinox Biotech
  • Wondfo
  • Easy@Home
  • BlueCross
  • Fairhaven Health
  • PRIMA Lab
  • Cyclotest
  • Rohto
  • Lobeck Medical
  • QuidelOrtho
  • Mankind Consumer Products
  • Hangzhou Singclean Medical

Key Questions Answered

1. How big is the global Pregnancy and Ovulation Testing market?
2. What is the demand of the global Pregnancy and Ovulation Testing market?
3. What is the year over year growth of the global Pregnancy and Ovulation Testing market?
4. What is the total value of the global Pregnancy and Ovulation Testing market?
5. Who are the Major Players in the global Pregnancy and Ovulation Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Pregnancy and Ovulation Testing Introduction
1.2 World Pregnancy and Ovulation Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Pregnancy and Ovulation Testing Total Market by Region (by Headquarter Location)
  1.3.1 World Pregnancy and Ovulation Testing Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Pregnancy and Ovulation Testing Revenue (2021-2032)
  1.3.3 China Based Company Pregnancy and Ovulation Testing Revenue (2021-2032)
  1.3.4 Europe Based Company Pregnancy and Ovulation Testing Revenue (2021-2032)
  1.3.5 Japan Based Company Pregnancy and Ovulation Testing Revenue (2021-2032)
  1.3.6 South Korea Based Company Pregnancy and Ovulation Testing Revenue (2021-2032)
  1.3.7 ASEAN Based Company Pregnancy and Ovulation Testing Revenue (2021-2032)
  1.3.8 India Based Company Pregnancy and Ovulation Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Pregnancy and Ovulation Testing Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Pregnancy and Ovulation Testing Consumption Value (2021-2032)
2.2 World Pregnancy and Ovulation Testing Consumption Value by Region
  2.2.1 World Pregnancy and Ovulation Testing Consumption Value by Region (2021-2026)
  2.2.2 World Pregnancy and Ovulation Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Pregnancy and Ovulation Testing Consumption Value (2021-2032)
2.4 China Pregnancy and Ovulation Testing Consumption Value (2021-2032)
2.5 Europe Pregnancy and Ovulation Testing Consumption Value (2021-2032)
2.6 Japan Pregnancy and Ovulation Testing Consumption Value (2021-2032)
2.7 South Korea Pregnancy and Ovulation Testing Consumption Value (2021-2032)
2.8 ASEAN Pregnancy and Ovulation Testing Consumption Value (2021-2032)
2.9 India Pregnancy and Ovulation Testing Consumption Value (2021-2032)

3 WORLD PREGNANCY AND OVULATION TESTING COMPANIES COMPETITIVE ANALYSIS

3.1 World Pregnancy and Ovulation Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Pregnancy and Ovulation Testing Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Pregnancy and Ovulation Testing in 2025
  3.2.3 Global Concentration Ratios (CR8) for Pregnancy and Ovulation Testing in 2025
3.3 Pregnancy and Ovulation Testing Company Evaluation Quadrant
3.4 Pregnancy and Ovulation Testing Market: Overall Company Footprint Analysis
  3.4.1 Pregnancy and Ovulation Testing Market: Region Footprint
  3.4.2 Pregnancy and Ovulation Testing Market: Company Product Type Footprint
  3.4.3 Pregnancy and Ovulation Testing Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Pregnancy and Ovulation Testing Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Pregnancy and Ovulation Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Pregnancy and Ovulation Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Pregnancy and Ovulation Testing Consumption Value Comparison
  4.2.1 United States VS China: Pregnancy and Ovulation Testing Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Pregnancy and Ovulation Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Pregnancy and Ovulation Testing Companies and Market Share, 2021-2026
  4.3.1 United States Based Pregnancy and Ovulation Testing Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Pregnancy and Ovulation Testing Revenue, (2021-2026)
4.4 China Based Companies Pregnancy and Ovulation Testing Revenue and Market Share, 2021-2026
  4.4.1 China Based Pregnancy and Ovulation Testing Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Pregnancy and Ovulation Testing Revenue, (2021-2026)
4.5 Rest of World Based Pregnancy and Ovulation Testing Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Pregnancy and Ovulation Testing Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Pregnancy and Ovulation Testing Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Pregnancy and Ovulation Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Coloration Test
  5.2.2 Digital Test
5.3 Market Segment by Type
  5.3.1 World Pregnancy and Ovulation Testing Market Size by Type (2021-2026)
  5.3.2 World Pregnancy and Ovulation Testing Market Size by Type (2027-2032)
  5.3.3 World Pregnancy and Ovulation Testing Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY PURPOSE OF TESTING

6.1 World Pregnancy and Ovulation Testing Market Size Overview by Purpose of Testing: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Purpose of Testing
  6.2.1 Pregnancy Test
  6.2.2 Ovulation Test
6.3 Market Segment by Purpose of Testing
  6.3.1 World Pregnancy and Ovulation Testing Market Size by Purpose of Testing (2021-2026)
  6.3.2 World Pregnancy and Ovulation Testing Market Size by Purpose of Testing (2027-2032)
  6.3.3 World Pregnancy and Ovulation Testing Market Size Market Share by Purpose of Testing (2027-2032)

7 MARKET ANALYSIS BY BIOMARKER

7.1 World Pregnancy and Ovulation Testing Market Size Overview by Biomarker: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Biomarker
  7.2.1 hCG-Based Test
  7.2.2 LH-Based Test
  7.2.3 Multi-Hormone Test
7.3 Market Segment by Biomarker
  7.3.1 World Pregnancy and Ovulation Testing Market Size by Biomarker (2021-2026)
  7.3.2 World Pregnancy and Ovulation Testing Market Size by Biomarker (2027-2032)
  7.3.3 World Pregnancy and Ovulation Testing Market Size Market Share by Biomarker (2027-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World Pregnancy and Ovulation Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Fertility Centers
  8.2.2 Hospitals
  8.2.3 Clinics
  8.2.4 Others
8.3 Market Segment by Application
  8.3.1 World Pregnancy and Ovulation Testing Market Size by Application (2021-2026)
  8.3.2 World Pregnancy and Ovulation Testing Market Size by Application (2027-2032)
  8.3.3 World Pregnancy and Ovulation Testing Market Size Market Share by Application (2021-2032)

9 COMPANY PROFILES

9.1 SPD (Clearblue)
  9.1.1 SPD (Clearblue) Details
  9.1.2 SPD (Clearblue) Major Business
  9.1.3 SPD (Clearblue) Pregnancy and Ovulation Testing Product and Services
  9.1.4 SPD (Clearblue) Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.1.5 SPD (Clearblue) Recent Developments/Updates
  9.1.6 SPD (Clearblue) Competitive Strengths & Weaknesses
9.2 First Response
  9.2.1 First Response Details
  9.2.2 First Response Major Business
  9.2.3 First Response Pregnancy and Ovulation Testing Product and Services
  9.2.4 First Response Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.2.5 First Response Recent Developments/Updates
  9.2.6 First Response Competitive Strengths & Weaknesses
9.3 Gregory Pharmaceutical (e.p.t)
  9.3.1 Gregory Pharmaceutical (e.p.t) Details
  9.3.2 Gregory Pharmaceutical (e.p.t) Major Business
  9.3.3 Gregory Pharmaceutical (e.p.t) Pregnancy and Ovulation Testing Product and Services
  9.3.4 Gregory Pharmaceutical (e.p.t) Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.3.5 Gregory Pharmaceutical (e.p.t) Recent Developments/Updates
  9.3.6 Gregory Pharmaceutical (e.p.t) Competitive Strengths & Weaknesses
9.4 Equinox Biotech
  9.4.1 Equinox Biotech Details
  9.4.2 Equinox Biotech Major Business
  9.4.3 Equinox Biotech Pregnancy and Ovulation Testing Product and Services
  9.4.4 Equinox Biotech Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.4.5 Equinox Biotech Recent Developments/Updates
  9.4.6 Equinox Biotech Competitive Strengths & Weaknesses
9.5 Wondfo
  9.5.1 Wondfo Details
  9.5.2 Wondfo Major Business
  9.5.3 Wondfo Pregnancy and Ovulation Testing Product and Services
  9.5.4 Wondfo Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.5.5 Wondfo Recent Developments/Updates
  9.5.6 Wondfo Competitive Strengths & Weaknesses
9.6 Easy@Home
  9.6.1 Easy@Home Details
  9.6.2 Easy@Home Major Business
  9.6.3 Easy@Home Pregnancy and Ovulation Testing Product and Services
  9.6.4 Easy@Home Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.6.5 Easy@Home Recent Developments/Updates
  9.6.6 Easy@Home Competitive Strengths & Weaknesses
9.7 BlueCross
  9.7.1 BlueCross Details
  9.7.2 BlueCross Major Business
  9.7.3 BlueCross Pregnancy and Ovulation Testing Product and Services
  9.7.4 BlueCross Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.7.5 BlueCross Recent Developments/Updates
  9.7.6 BlueCross Competitive Strengths & Weaknesses
9.8 Fairhaven Health
  9.8.1 Fairhaven Health Details
  9.8.2 Fairhaven Health Major Business
  9.8.3 Fairhaven Health Pregnancy and Ovulation Testing Product and Services
  9.8.4 Fairhaven Health Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.8.5 Fairhaven Health Recent Developments/Updates
  9.8.6 Fairhaven Health Competitive Strengths & Weaknesses
9.9 PRIMA Lab
  9.9.1 PRIMA Lab Details
  9.9.2 PRIMA Lab Major Business
  9.9.3 PRIMA Lab Pregnancy and Ovulation Testing Product and Services
  9.9.4 PRIMA Lab Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.9.5 PRIMA Lab Recent Developments/Updates
  9.9.6 PRIMA Lab Competitive Strengths & Weaknesses
9.10 Cyclotest
  9.10.1 Cyclotest Details
  9.10.2 Cyclotest Major Business
  9.10.3 Cyclotest Pregnancy and Ovulation Testing Product and Services
  9.10.4 Cyclotest Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.10.5 Cyclotest Recent Developments/Updates
  9.10.6 Cyclotest Competitive Strengths & Weaknesses
9.11 Rohto
  9.11.1 Rohto Details
  9.11.2 Rohto Major Business
  9.11.3 Rohto Pregnancy and Ovulation Testing Product and Services
  9.11.4 Rohto Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.11.5 Rohto Recent Developments/Updates
  9.11.6 Rohto Competitive Strengths & Weaknesses
9.12 Lobeck Medical
  9.12.1 Lobeck Medical Details
  9.12.2 Lobeck Medical Major Business
  9.12.3 Lobeck Medical Pregnancy and Ovulation Testing Product and Services
  9.12.4 Lobeck Medical Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.12.5 Lobeck Medical Recent Developments/Updates
  9.12.6 Lobeck Medical Competitive Strengths & Weaknesses
9.13 QuidelOrtho
  9.13.1 QuidelOrtho Details
  9.13.2 QuidelOrtho Major Business
  9.13.3 QuidelOrtho Pregnancy and Ovulation Testing Product and Services
  9.13.4 QuidelOrtho Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.13.5 QuidelOrtho Recent Developments/Updates
  9.13.6 QuidelOrtho Competitive Strengths & Weaknesses
9.14 Mankind Consumer Products
  9.14.1 Mankind Consumer Products Details
  9.14.2 Mankind Consumer Products Major Business
  9.14.3 Mankind Consumer Products Pregnancy and Ovulation Testing Product and Services
  9.14.4 Mankind Consumer Products Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.14.5 Mankind Consumer Products Recent Developments/Updates
  9.14.6 Mankind Consumer Products Competitive Strengths & Weaknesses
9.15 Hangzhou Singclean Medical
  9.15.1 Hangzhou Singclean Medical Details
  9.15.2 Hangzhou Singclean Medical Major Business
  9.15.3 Hangzhou Singclean Medical Pregnancy and Ovulation Testing Product and Services
  9.15.4 Hangzhou Singclean Medical Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026)
  9.15.5 Hangzhou Singclean Medical Recent Developments/Updates
  9.15.6 Hangzhou Singclean Medical Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Pregnancy and Ovulation Testing Industry Chain
10.2 Pregnancy and Ovulation Testing Upstream Analysis
10.3 Pregnancy and Ovulation Testing Midstream Analysis
10.4 Pregnancy and Ovulation Testing Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES

Table 1. World Pregnancy and Ovulation Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Pregnancy and Ovulation Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Pregnancy and Ovulation Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Pregnancy and Ovulation Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Pregnancy and Ovulation Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pregnancy and Ovulation Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Pregnancy and Ovulation Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Pregnancy and Ovulation Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Pregnancy and Ovulation Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Pregnancy and Ovulation Testing Players in 2025
Table 12. World Pregnancy and Ovulation Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Pregnancy and Ovulation Testing Company Evaluation Quadrant
Table 14. Head Office of Key Pregnancy and Ovulation Testing Players
Table 15. Pregnancy and Ovulation Testing Market: Company Product Type Footprint
Table 16. Pregnancy and Ovulation Testing Market: Company Product Application Footprint
Table 17. Pregnancy and Ovulation Testing Mergers & Acquisitions Activity
Table 18. United States VS China Pregnancy and Ovulation Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Pregnancy and Ovulation Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Pregnancy and Ovulation Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pregnancy and Ovulation Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Pregnancy and Ovulation Testing Revenue Market Share (2021-2026)
Table 23. China Based Pregnancy and Ovulation Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pregnancy and Ovulation Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Pregnancy and Ovulation Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Pregnancy and Ovulation Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Pregnancy and Ovulation Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Pregnancy and Ovulation Testing Revenue Market Share (2021-2026)
Table 29. World Pregnancy and Ovulation Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Pregnancy and Ovulation Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Pregnancy and Ovulation Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Pregnancy and Ovulation Testing Market Size by Purpose of Testing, (USD Million), 2021 & 2025 & 2032
Table 33. World Pregnancy and Ovulation Testing Market Size Value by Purpose of Testing (2021-2026) & (USD Million)
Table 34. World Pregnancy and Ovulation Testing Market Size by Purpose of Testing (2027-2032) & (USD Million)
Table 35. World Pregnancy and Ovulation Testing Market Size by Biomarker, (USD Million), 2021 & 2025 & 2032
Table 36. World Pregnancy and Ovulation Testing Market Size Value by Biomarker (2021-2026) & (USD Million)
Table 37. World Pregnancy and Ovulation Testing Market Size by Biomarker (2027-2032) & (USD Million)
Table 38. World Pregnancy and Ovulation Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Pregnancy and Ovulation Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Pregnancy and Ovulation Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. SPD (Clearblue) Basic Information, Manufacturing Base and Competitors
Table 42. SPD (Clearblue) Major Business
Table 43. SPD (Clearblue) Pregnancy and Ovulation Testing Product and Services
Table 44. SPD (Clearblue) Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. SPD (Clearblue) Recent Developments/Updates
Table 46. SPD (Clearblue) Competitive Strengths & Weaknesses
Table 47. First Response Basic Information, Manufacturing Base and Competitors
Table 48. First Response Major Business
Table 49. First Response Pregnancy and Ovulation Testing Product and Services
Table 50. First Response Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. First Response Recent Developments/Updates
Table 52. First Response Competitive Strengths & Weaknesses
Table 53. Gregory Pharmaceutical (e.p.t) Basic Information, Manufacturing Base and Competitors
Table 54. Gregory Pharmaceutical (e.p.t) Major Business
Table 55. Gregory Pharmaceutical (e.p.t) Pregnancy and Ovulation Testing Product and Services
Table 56. Gregory Pharmaceutical (e.p.t) Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Gregory Pharmaceutical (e.p.t) Recent Developments/Updates
Table 58. Gregory Pharmaceutical (e.p.t) Competitive Strengths & Weaknesses
Table 59. Equinox Biotech Basic Information, Manufacturing Base and Competitors
Table 60. Equinox Biotech Major Business
Table 61. Equinox Biotech Pregnancy and Ovulation Testing Product and Services
Table 62. Equinox Biotech Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Equinox Biotech Recent Developments/Updates
Table 64. Equinox Biotech Competitive Strengths & Weaknesses
Table 65. Wondfo Basic Information, Manufacturing Base and Competitors
Table 66. Wondfo Major Business
Table 67. Wondfo Pregnancy and Ovulation Testing Product and Services
Table 68. Wondfo Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Wondfo Recent Developments/Updates
Table 70. Wondfo Competitive Strengths & Weaknesses
Table 71. Easy@Home Basic Information, Manufacturing Base and Competitors
Table 72. Easy@Home Major Business
Table 73. Easy@Home Pregnancy and Ovulation Testing Product and Services
Table 74. Easy@Home Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Easy@Home Recent Developments/Updates
Table 76. Easy@Home Competitive Strengths & Weaknesses
Table 77. BlueCross Basic Information, Manufacturing Base and Competitors
Table 78. BlueCross Major Business
Table 79. BlueCross Pregnancy and Ovulation Testing Product and Services
Table 80. BlueCross Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. BlueCross Recent Developments/Updates
Table 82. BlueCross Competitive Strengths & Weaknesses
Table 83. Fairhaven Health Basic Information, Manufacturing Base and Competitors
Table 84. Fairhaven Health Major Business
Table 85. Fairhaven Health Pregnancy and Ovulation Testing Product and Services
Table 86. Fairhaven Health Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Fairhaven Health Recent Developments/Updates
Table 88. Fairhaven Health Competitive Strengths & Weaknesses
Table 89. PRIMA Lab Basic Information, Manufacturing Base and Competitors
Table 90. PRIMA Lab Major Business
Table 91. PRIMA Lab Pregnancy and Ovulation Testing Product and Services
Table 92. PRIMA Lab Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. PRIMA Lab Recent Developments/Updates
Table 94. PRIMA Lab Competitive Strengths & Weaknesses
Table 95. Cyclotest Basic Information, Manufacturing Base and Competitors
Table 96. Cyclotest Major Business
Table 97. Cyclotest Pregnancy and Ovulation Testing Product and Services
Table 98. Cyclotest Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Cyclotest Recent Developments/Updates
Table 100. Cyclotest Competitive Strengths & Weaknesses
Table 101. Rohto Basic Information, Manufacturing Base and Competitors
Table 102. Rohto Major Business
Table 103. Rohto Pregnancy and Ovulation Testing Product and Services
Table 104. Rohto Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Rohto Recent Developments/Updates
Table 106. Rohto Competitive Strengths & Weaknesses
Table 107. Lobeck Medical Basic Information, Manufacturing Base and Competitors
Table 108. Lobeck Medical Major Business
Table 109. Lobeck Medical Pregnancy and Ovulation Testing Product and Services
Table 110. Lobeck Medical Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lobeck Medical Recent Developments/Updates
Table 112. Lobeck Medical Competitive Strengths & Weaknesses
Table 113. QuidelOrtho Basic Information, Manufacturing Base and Competitors
Table 114. QuidelOrtho Major Business
Table 115. QuidelOrtho Pregnancy and Ovulation Testing Product and Services
Table 116. QuidelOrtho Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. QuidelOrtho Recent Developments/Updates
Table 118. QuidelOrtho Competitive Strengths & Weaknesses
Table 119. Mankind Consumer Products Basic Information, Manufacturing Base and Competitors
Table 120. Mankind Consumer Products Major Business
Table 121. Mankind Consumer Products Pregnancy and Ovulation Testing Product and Services
Table 122. Mankind Consumer Products Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Mankind Consumer Products Recent Developments/Updates
Table 124. Mankind Consumer Products Competitive Strengths & Weaknesses
Table 125. Hangzhou Singclean Medical Basic Information, Manufacturing Base and Competitors
Table 126. Hangzhou Singclean Medical Major Business
Table 127. Hangzhou Singclean Medical Pregnancy and Ovulation Testing Product and Services
Table 128. Hangzhou Singclean Medical Pregnancy and Ovulation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Hangzhou Singclean Medical Recent Developments/Updates
Table 130. Hangzhou Singclean Medical Competitive Strengths & Weaknesses
Table 131. Global Key Players of Pregnancy and Ovulation Testing Upstream (Raw Materials)
Table 132. Global Pregnancy and Ovulation Testing Typical Customers

LIST OF FIGURES

Figure 1. Pregnancy and Ovulation Testing Picture
Figure 2. World Pregnancy and Ovulation Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pregnancy and Ovulation Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Pregnancy and Ovulation Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Pregnancy and Ovulation Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Pregnancy and Ovulation Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Pregnancy and Ovulation Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Pregnancy and Ovulation Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Pregnancy and Ovulation Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Pregnancy and Ovulation Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Pregnancy and Ovulation Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Pregnancy and Ovulation Testing Revenue (2021-2032) & (USD Million)
Figure 13. Pregnancy and Ovulation Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Pregnancy and Ovulation Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Pregnancy and Ovulation Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Pregnancy and Ovulation Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pregnancy and Ovulation Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pregnancy and Ovulation Testing Markets in 2025
Figure 27. United States VS China: Pregnancy and Ovulation Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pregnancy and Ovulation Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Pregnancy and Ovulation Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Pregnancy and Ovulation Testing Market Size Market Share by Type in 2025
Figure 31. Coloration Test
Figure 32. Digital Test
Figure 33. World Pregnancy and Ovulation Testing Market Size Market Share by Type (2021-2032)
Figure 34. World Pregnancy and Ovulation Testing Market Size by Purpose of Testing, (USD Million), 2021 & 2025 & 2032
Figure 35. World Pregnancy and Ovulation Testing Market Size Market Share by Purpose of Testing in 2025
Figure 36. Pregnancy Test
Figure 37. Ovulation Test
Figure 38. World Pregnancy and Ovulation Testing Market Size Market Share by Purpose of Testing (2021-2032)
Figure 39. World Pregnancy and Ovulation Testing Market Size by Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 40. World Pregnancy and Ovulation Testing Market Size Market Share by Biomarker in 2025
Figure 41. hCG-Based Test
Figure 42. LH-Based Test
Figure 43. Multi-Hormone Test
Figure 44. World Pregnancy and Ovulation Testing Market Size Market Share by Biomarker (2021-2032)
Figure 45. World Pregnancy and Ovulation Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Pregnancy and Ovulation Testing Market Size Market Share by Application in 2025
Figure 47. Fertility Centers
Figure 48. Hospitals
Figure 49. Clinics
Figure 50. Others
Figure 51. World Pregnancy and Ovulation Testing Market Size Market Share by Application (2021-2032)
Figure 52. Pregnancy and Ovulation Testing Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source